Celladon Corporation Announces Upcoming Presentations at American Heart Association Scientific Sessions 2009

SAN DIEGO--(BUSINESS WIRE)--Celladon Corporation, developing therapies for the treatment of heart failure, today announced upcoming data presentations at the American Heart Association (AHA) Scientific Sessions, November 14-18, 2009, Orlando, Florida.

MORE ON THIS TOPIC